BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25825141)

  • 1. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo.
    Zhong X; Lin J; Zhou J; Xu W; Hong Z
    Mol Med Rep; 2015 Aug; 12(2):1699-708. PubMed ID: 25825141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the signal transducer and activator of transcription 3 signaling pathway by Qianliening capsules suppresses the growth and induces the apoptosis of human prostate cells.
    Lin J; Zhou J; Zhong X; Hong Z; Peng J
    Mol Med Rep; 2015 Mar; 11(3):2207-14. PubMed ID: 25394909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Qianliening capsule treats benign prostatic hyperplasia via induction of prostatic cell apoptosis.
    Zheng H; Xu W; Lin J; Peng J; Hong Z
    Mol Med Rep; 2013 Mar; 7(3):848-54. PubMed ID: 23314795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psoralea corylifolia L. extract ameliorates benign prostatic hyperplasia by regulating prostate cell proliferation and apoptosis.
    Kim HJ; Jin BR; An HJ
    J Ethnopharmacol; 2021 Jun; 273():113844. PubMed ID: 33485982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
    Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
    J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Proliferative Effects of Standardized
    Jin BR; Cheon SY; Kim HJ; Kim MS; Lee KH; An HJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33334082
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of Xialiqi Capsules on the expressions of PCNA and caspase-3 in rats withbenign prostatic hyperplasia].
    Cai HC; Song LB; Zhang GW; Qing XR; Mo DS; Liu W; Zhan XX; Huang YF; Shang XJ
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):728-733. PubMed ID: 29726649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quisqualis indica Improves Benign Prostatic Hyperplasia by Regulating Prostate Cell Proliferation and Apoptosis.
    Ub Wijerathne C; Park HS; Jeong HY; Song JW; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Yeon SH; Kwun HJ
    Biol Pharm Bull; 2017 Dec; 40(12):2125-2133. PubMed ID: 28943529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Banana Flower Extract Suppresses Benign Prostatic Hyperplasia by Regulating the Inflammatory Response and Inducing G
    Liu LC; Lin YH; Lin YC; Ho CT; Hung CM; Way TD; Bau DT
    In Vivo; 2018; 32(6):1373-1379. PubMed ID: 30348691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Kangquan Recipe on sex steroids and cell proliferation in rats with benign prostatic hyperplasia.
    Huang YP; Du J; Hong ZF; Chen ZQ; Wu JF; Zhao JY
    Chin J Integr Med; 2009 Aug; 15(4):289-92. PubMed ID: 19688318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevention and treatment effects of tanshinone IIA on oestrogen/androgen-induced benign prostatic hyperplasia in rats.
    Wang C; Du X; Yang R; Liu J; Xu D; Shi J; Chen L; Shao R; Fan G; Gao X; Tian G; Zhu Y; Zhang J
    J Steroid Biochem Mol Biol; 2015 Jan; 145():28-37. PubMed ID: 25290459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Veratrum maackii on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
    Park HS; Seo CS; Wijerathne CU; Jeong HY; Moon OS; Seo YW; Won YS; Son HY; Lim JH; Kwun HJ
    Biol Pharm Bull; 2019 Jan; 42(1):1-9. PubMed ID: 30381617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Umbelliferone Ameliorates Benign Prostatic Hyperplasia by Inhibiting Cell Proliferation and G1/S Phase Cell Cycle Progression through Regulation of STAT3/E2F1 Axis.
    Kim HJ; Jin BR; An HJ
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.
    Hong ZF; Lin JM; Zhong XY; Li Y; Zhou JH; Xu W; Peng J
    Chin J Integr Med; 2012 Nov; 18(11):824-30. PubMed ID: 23086486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
    Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
    Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcuma oil ameliorates benign prostatic hyperplasia through suppression of the nuclear factor-kappa B signaling pathway in rats.
    Wang S; Li Y; Li W; Zhang K; Yuan Z; Cai Y; Xu K; Zhou J; Du Z
    J Ethnopharmacol; 2021 Oct; 279():113703. PubMed ID: 33340599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qianliening capsules influence the apoptosis of benign prostatic hyperplasia epithelial-1 cells by regulating the extracellular matrix.
    Zhou J; Lin J; Liu L; Zheng Y; Hong Z
    Mol Med Rep; 2015 May; 11(5):3734-40. PubMed ID: 25592406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway.
    Lin J; Zhou J; Xu W; Hong Z; Peng J
    Exp Ther Med; 2014 Jul; 8(1):118-124. PubMed ID: 24944609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of cGMP/PKG/p65 signaling associated with PDE5-Is downregulates CCL5 secretion by CD8
    Jin S; Xiang P; Liu J; Yang Y; Hu S; Sheng J; He Q; Yu W; Han W; Jin J; Peng J
    Prostate; 2019 Jun; 79(8):909-919. PubMed ID: 30958912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
    Rick FG; Schally AV; Block NL; Abi-Chaker A; Krishan A; Szalontay L
    Prostate; 2013 Jun; 73(8):873-83. PubMed ID: 23280565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.